Trial
NCT04066751
The Multicenter Topic Trial
Phase IIWITHDRAWNOPERATIONALConfidence: HIGH
Sponsor
University of Alabama at Birmingham
Collaborators
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); Vertex Pharmaceuticals Incorporated
Condition
Chronic Obstructive Pulmonary Disease
Intervention
Ivacaftor
Why stopped
Study never started due to change in availability of study drug
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2022-01-27